News from emd serono, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 27, 2014, 08:00 ET

EMD Serono Announces Award of $1.3 Million to the Winners of the first Grant for Oncology Innovation

 EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for...

Sep 19, 2014, 03:39 ET

EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time

- The first grants awarded to coincide with the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting  - Investment...

Sep 12, 2014, 08:00 ET
EMD Serono. (PRNewsFoto/EMD Serono)

EMD Serono Honors Recipients of the Second Annual EUR 1 Million Grant for Multiple Sclerosis Innovation

 EMD Serono Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the recipients of the second annual Grant for...

Sep 10, 2014, 09:00 ET
EMD Serono. (PRNewsFoto/EMD Serono)

EMD Serono and Accelerated Cure Project Launch Collaborative Research Program to Optimize Treatment and Understand Progression of Multiple Sclerosis

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany and the Accelerated Cure Project for Multiple Sclerosis today...

Sep 09, 2014, 15:00 ET
EMD Serono. (PRNewsFoto/EMD Serono)

EMD Serono Presents New Data on Rebif ® (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the division's multiple sclerosis...

Sep 02, 2014, 09:00 ET
Drew Young, Senior Vice President, Neurology and Immunology at EMD Serono, Inc. (PRNewsFoto/EMD Serono)

EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Drew Young has joined the company as Senior Vice...

Jul 29, 2014, 02:30 ET

EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma

  - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients...

Jul 01, 2014, 09:00 ET

EMD Serono Commits EUR 2 million to the Grant for Fertility Innovation (GFI) for 2014 /15

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced its strong support of the Grant for Fertility Innovation...

Jun 24, 2014, 07:30 ET
EMD Serono (PRNewsFoto/EMD Serono)

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Mersana Therapeutics, Inc., Cambridge, Mass., U.S., announced today an...

Jun 11, 2014, 09:00 ET

EMD Serono Launches Compassionate Corps Program to Reduce Cost of Fertility Treatment for Eligible Military Veterans and their Spouses

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany announced today its commitment to U.S. military veterans and their spouses...

May 29, 2014, 02:30 ET

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers

ASCO abstract #: Anti-PD-L1: 3064; c-Met: 2521, TPS4151, TPS8121; tecemotide: TPS3658, TPS7608; TH-302: 8534, 2029; further pipeline: 3551,...

May 28, 2014, 09:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Demonstrates Continued Commitment to Patients with Relapsing MS

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Rebif®  (interferon beta-1a) data will be...

Apr 25, 2014, 09:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Presents New Data on Rebif® (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS)...

Apr 07, 2014, 02:20 ET

EMD Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer

   - First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries   -...

Apr 01, 2014, 08:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono, Inc. Launches 10th Edition of The EMD Serono Specialty Digest™ at Annual Meeting of The Academy of Managed Care Pharmacy

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the launch of the 10th edition of the EMD Serono...

Apr 01, 2014, 07:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Enters into Research Agreement with Pfizer and Broad Institute

EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and...

Dec 17, 2013, 09:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono, Inc. and the National MS Society Announce Recipients of Funding for Multiple Sclerosis Research

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and the National Multiple Sclerosis Society through Fast Forward...

Dec 16, 2013, 08:30 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono's Redesigned Fertility Pen Available for Distribution in US

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Gonal-f® RFF Redi-ject™, a disposable...

Oct 05, 2013, 08:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Makes First Awards as Part of the Company's 1 Million Euro Grant for Multiple Sclerosis Innovation

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today on the occasion of the 29th European Committee...

Oct 01, 2013, 09:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is the founding supporter of the newly launched...